Epie Boven

PROF.DR.

19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes

Kruger, D. T., Opdam, M., Sanders, J., van der Noort, V., Boven, E. & Linn, S. C., 24 Jan 2020, In : APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 128, 4, 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer

Kruger, D. T., Alexi, X., Opdam, M., Schuurman, K., Voorwerk, L., Sanders, J., van der Noort, V., Boven, E., Zwart, W. & Linn, S. C., 15 Apr 2020, In : International Journal of Cancer. 146, 8, p. 2348-2359 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study

Mammatas, L. H., Venema, C. M., Schröder, C. P., de Vet, H. C. W., van Kruchten, M., Glaudemans, A. W. J. M., Yaqub, M. M., Verheul, H. M. W., Boven, E., van der Vegt, B., de Vries, E. F. J., de Vries, E. G. E., Hoekstra, O. S., Hospers, G. A. P. & der Houven van Oordt, C. W. M. V., 1 Jan 2020, In : EJNMMI Research. 10, 1, 40.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2- postmenopausal breast cancer patients treated with everolimus and exemestane

Kruger, D. T., Jansen, M. P. H. M., Konings, I. R. H. M., Dercksen, W. M., Jager, A., Oulad Hadj, J., Sleijfer, S., Martens, J. W. M. & Boven, E., 16 Dec 2019, In : Molecular oncology.

Research output: Contribution to journalArticleAcademicpeer-review

A genetic polymorphism in ctla-4 is associated with overall survival in sunitinib-treated patients with clear cell metastatic renal cell carcinoma

Liu, X., Swen, J. J., Diekstra, M. H. M., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H. J., Vermeulen, S. H., Oosterwijk, E., Junker, K., Roessler, M., Alexiusdottir, K., Sverrisdottir, A., Radu, M. T., Ambert, V., Eisen, T., Warren, A., Rodríguez-Antona, C., García-Donas, J., Bohringer, S. & 4 others, Koudijs, K. K. M., Kiemeney, L. A. L. M., Rini, B. I. & Guchelaar, H-J., 2018, In : Clinical Cancer Research. 24, 10, p. 2350-2356

Research output: Contribution to journalArticleAcademicpeer-review